Cargando…
A Nanosized Codelivery System Based on Intracellular Stimuli-Triggered Dual-Drug Release for Multilevel Chemotherapy Amplification in Drug-Resistant Breast Cancer
Lacking nano-systems for precisely codelivering the chemotherapeutics paclitaxel (PTX) and the natural P-glycoprotein (P-gp) inhibitor, quercetin (QU), into cancer cells and controlling their intracellular release extremely decreased the anticancer effects in multidrug resistant (MDR) tumors. To ove...
Autores principales: | Guo, Yufan, Liu, Shuo, Luo, Fazhen, Tang, Dongyun, Yang, Tianshu, Yang, Xiuru, Xie, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878749/ https://www.ncbi.nlm.nih.gov/pubmed/35214154 http://dx.doi.org/10.3390/pharmaceutics14020422 |
Ejemplares similares
-
Intracellular codelivery of anti-inflammatory drug and anti-miR 155 to treat inflammatory disease
por: Teng, Chao, et al.
Publicado: (2020) -
Microemulsion-based synergistic dual-drug codelivery system for enhanced apoptosis of tumor cells
por: Qu, Ding, et al.
Publicado: (2015) -
Nucleus-selective codelivery of proteins and drugs for synergistic antitumor therapy
por: Yang, Lan, et al.
Publicado: (2022) -
Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers
por: Kumar, Girish, et al.
Publicado: (2023) -
Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
por: Zhang, Yi, et al.
Publicado: (2018)